vs

Side-by-side financial comparison of CSW INDUSTRIALS, INC. (CSW) and Varex Imaging Corp (VREX). Click either name above to swap in a different company.

CSW INDUSTRIALS, INC. is the larger business by last-quarter revenue ($233.0M vs $209.6M, roughly 1.1× Varex Imaging Corp). CSW INDUSTRIALS, INC. runs the higher net margin — 4.4% vs 1.1%, a 3.3% gap on every dollar of revenue. On growth, CSW INDUSTRIALS, INC. posted the faster year-over-year revenue change (20.3% vs 4.9%). CSW INDUSTRIALS, INC. produced more free cash flow last quarter ($22.7M vs $-26.8M). Over the past eight quarters, CSW INDUSTRIALS, INC.'s revenue compounded faster (5.1% CAGR vs 0.8%).

Varex Imaging Corp is a global supplier of advanced imaging components and solutions, including X-ray tubes, digital flat panel detectors, and image processing software. Its products serve medical imaging, radiation oncology, and industrial non-destructive testing segments, with customers across key global markets.

CSW vs VREX — Head-to-Head

Bigger by revenue
CSW
CSW
1.1× larger
CSW
$233.0M
$209.6M
VREX
Growing faster (revenue YoY)
CSW
CSW
+15.4% gap
CSW
20.3%
4.9%
VREX
Higher net margin
CSW
CSW
3.3% more per $
CSW
4.4%
1.1%
VREX
More free cash flow
CSW
CSW
$49.5M more FCF
CSW
$22.7M
$-26.8M
VREX
Faster 2-yr revenue CAGR
CSW
CSW
Annualised
CSW
5.1%
0.8%
VREX

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
CSW
CSW
VREX
VREX
Revenue
$233.0M
$209.6M
Net Profit
$10.3M
$2.3M
Gross Margin
39.7%
33.3%
Operating Margin
7.4%
7.3%
Net Margin
4.4%
1.1%
Revenue YoY
20.3%
4.9%
Net Profit YoY
-61.9%
866.7%
EPS (diluted)
$0.62
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CSW
CSW
VREX
VREX
Q1 26
$209.6M
Q4 25
$233.0M
$228.9M
Q3 25
$277.0M
$203.0M
Q2 25
$263.6M
$212.9M
Q1 25
$230.5M
$199.8M
Q4 24
$193.6M
Q3 24
$227.9M
$205.7M
Q2 24
$226.2M
$209.1M
Net Profit
CSW
CSW
VREX
VREX
Q1 26
$2.3M
Q4 25
$10.3M
$12.2M
Q3 25
$40.7M
$-89.1M
Q2 25
$40.9M
$6.9M
Q1 25
$35.1M
$-300.0K
Q4 24
$26.9M
Q3 24
$36.1M
$-51.1M
Q2 24
$38.6M
$1.4M
Gross Margin
CSW
CSW
VREX
VREX
Q1 26
33.3%
Q4 25
39.7%
34.0%
Q3 25
43.0%
33.3%
Q2 25
43.8%
36.0%
Q1 25
44.2%
34.3%
Q4 24
41.4%
Q3 24
45.6%
32.6%
Q2 24
47.5%
32.0%
Operating Margin
CSW
CSW
VREX
VREX
Q1 26
7.3%
Q4 25
7.4%
8.6%
Q3 25
20.5%
-39.8%
Q2 25
20.8%
10.4%
Q1 25
19.5%
5.6%
Q4 24
15.3%
Q3 24
22.6%
5.3%
Q2 24
24.3%
4.4%
Net Margin
CSW
CSW
VREX
VREX
Q1 26
1.1%
Q4 25
4.4%
5.3%
Q3 25
14.7%
-43.9%
Q2 25
15.5%
3.2%
Q1 25
15.2%
-0.2%
Q4 24
13.9%
Q3 24
15.8%
-24.8%
Q2 24
17.1%
0.7%
EPS (diluted)
CSW
CSW
VREX
VREX
Q1 26
$0.05
Q4 25
$0.62
$0.29
Q3 25
$2.41
$-2.15
Q2 25
$2.43
$0.17
Q1 25
$2.05
$-0.01
Q4 24
$1.60
Q3 24
$2.26
$-1.25
Q2 24
$2.47
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CSW
CSW
VREX
VREX
Cash + ST InvestmentsLiquidity on hand
$40.2M
$125.6M
Total DebtLower is stronger
$367.6M
Stockholders' EquityBook value
$1.1B
$476.9M
Total Assets
$2.3B
$1.1B
Debt / EquityLower = less leverage
0.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CSW
CSW
VREX
VREX
Q1 26
$125.6M
Q4 25
$40.2M
$155.1M
Q3 25
$31.5M
$152.6M
Q2 25
$38.0M
$223.0M
Q1 25
$225.8M
$212.6M
Q4 24
$213.8M
Q3 24
$273.2M
$200.5M
Q2 24
$18.9M
$190.0M
Total Debt
CSW
CSW
VREX
VREX
Q1 26
$367.6M
Q4 25
$367.5M
Q3 25
$367.5M
Q2 25
$567.2M
Q1 25
$800.1M
$567.0M
Q4 24
Q3 24
$443.4M
Q2 24
$443.1M
Stockholders' Equity
CSW
CSW
VREX
VREX
Q1 26
$476.9M
Q4 25
$1.1B
$472.6M
Q3 25
$1.1B
$455.3M
Q2 25
$1.1B
$549.7M
Q1 25
$1.1B
$540.2M
Q4 24
$1.0B
Q3 24
$1.0B
$529.1M
Q2 24
$650.2M
$581.2M
Total Assets
CSW
CSW
VREX
VREX
Q1 26
$1.1B
Q4 25
$2.3B
$1.1B
Q3 25
$1.5B
$1.1B
Q2 25
$1.5B
$1.4B
Q1 25
$1.4B
$1.3B
Q4 24
$1.4B
Q3 24
$1.4B
$1.2B
Q2 24
$1.1B
$1.3B
Debt / Equity
CSW
CSW
VREX
VREX
Q1 26
0.77×
Q4 25
0.78×
Q3 25
0.81×
Q2 25
1.03×
Q1 25
0.75×
1.05×
Q4 24
Q3 24
0.84×
Q2 24
0.76×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CSW
CSW
VREX
VREX
Operating Cash FlowLast quarter
$28.9M
$-16.1M
Free Cash FlowOCF − Capex
$22.7M
$-26.8M
FCF MarginFCF / Revenue
9.8%
-12.8%
Capex IntensityCapex / Revenue
2.6%
5.1%
Cash ConversionOCF / Net Profit
2.81×
-7.00×
TTM Free Cash FlowTrailing 4 quarters
$162.0M
$-13.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CSW
CSW
VREX
VREX
Q1 26
$-16.1M
Q4 25
$28.9M
$7.9M
Q3 25
$61.8M
$7.7M
Q2 25
$60.6M
$16.6M
Q1 25
$27.3M
$9.5M
Q4 24
$11.6M
Q3 24
$66.8M
$25.9M
Q2 24
$62.7M
$8.0M
Free Cash Flow
CSW
CSW
VREX
VREX
Q1 26
$-26.8M
Q4 25
$22.7M
$2.3M
Q3 25
$58.7M
$1.4M
Q2 25
$57.7M
$9.8M
Q1 25
$22.8M
$5.3M
Q4 24
$8.5M
Q3 24
$61.3M
$19.9M
Q2 24
$59.6M
$3.3M
FCF Margin
CSW
CSW
VREX
VREX
Q1 26
-12.8%
Q4 25
9.8%
1.0%
Q3 25
21.2%
0.7%
Q2 25
21.9%
4.6%
Q1 25
9.9%
2.7%
Q4 24
4.4%
Q3 24
26.9%
9.7%
Q2 24
26.3%
1.6%
Capex Intensity
CSW
CSW
VREX
VREX
Q1 26
5.1%
Q4 25
2.6%
2.4%
Q3 25
1.1%
3.1%
Q2 25
1.1%
3.2%
Q1 25
2.0%
2.1%
Q4 24
1.6%
Q3 24
2.4%
2.9%
Q2 24
1.4%
2.2%
Cash Conversion
CSW
CSW
VREX
VREX
Q1 26
-7.00×
Q4 25
2.81×
0.65×
Q3 25
1.52×
Q2 25
1.48×
2.41×
Q1 25
0.78×
Q4 24
0.43×
Q3 24
1.85×
Q2 24
1.62×
5.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CSW
CSW

Contractor Solutions Segment$166.3M71%
Specialized Reliability Solutions Segment$38.2M16%
Engineered Building Solutions Segment$28.5M12%

VREX
VREX

Medical Segment$144.8M69%
Industrial Segment$64.8M31%

Related Comparisons